Botanical species · safety record

Duranta erecta

The EFSA Compendium of Botanicals holds 2 constituent measurements and 4 adverse-effect records for Duranta erecta. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Duranta erecta L.

2Constituent measurements

4Safety records

3Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Coumarinolignoids	Unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Saponins	Aerial part of plants	Solvent extraction	—	Phytochemical screening	Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Aerial part of plants	—	Cat (as animal)	Case report	Resolve DOI
Digestive	Digestive	Aerial part of plants	—	Dog (as animal)	Case report	Resolve DOI
Neurotoxicity	Neurologic	Aerial part of plants	—	Dog (as animal)	Case report	Resolve DOI
Neurotoxicity	Neurologic	Aerial part of plants	—	Cat (as animal)	Case report	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Shahat, A.A., Nazif, N.M., Abousetta, L.M., Ibrahim, N.A., Cos, P., Van Miert, S., Pieters, L., Vlietinck, A.J. Phytochemical investigation and antioxidant activity of Duranta repens. Phytotherapy Research, 2005, vol. 19, no. 12, p. 1071-1073. DOI
Ahmad, N., Zeb, F., Ahmad, I., Wang, F. Repenins A-D, four new antioxidative coumarinolignoids from Duranta repens Linn.. Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, no. 13, p. 3521-3524. DOI
Scanlan, S. N. A., Eagles, D. A., Vacher, N. E., Irvine, M. A., Ryan, C. J., Mckenzie, R. A. Duranta erecta poisoning in nine dogs and a cat. AUSTRALIAN VETERINARY JOURNAL, 2006, vol. 84, no. 10, p. 367-370. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature